BRYNN PEMBROKE: Open Payments
NPI 1033453295 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 86 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $270 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| Noven Therapeutics, LLC | 17 | $227 |
| Axsome Therapeutics, Inc. | 6 | $224 |
| Alkermes, Inc. | 7 | $172 |
| ABBVIE INC. | 10 | $150 |
| Otsuka America Pharmaceutical, Inc. | 11 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $106 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
Products named: Xelstrym, Auvelity, REXULTI, ARISTADA, VRAYLAR, TRINTELLIX, INGREZZA, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
